Kymera Therapeutics, Inc. (KYMR)
83.85
-2.83
(-3.26%)
USD |
NASDAQ |
Apr 28, 16:00
83.97
+0.12
(+0.14%)
After-Hours: 20:00
Kymera Therapeutics Research and Development Expense (TTM) : 308.26M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Revolution Medicines, Inc. | 978.68M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Indivior Pharmaceuticals, Inc. | 80.00M |
| Structure Therapeutics, Inc. | 225.89M |